The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1478
ISSUE1478
September 28, 2015
Naloxegol (Movantik) for Opioid-Induced Constipation
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Naloxegol (Movantik) for Opioid-Induced Constipation
September 28, 2015 (Issue: 1478)
The FDA has approved naloxegol (Movantik –
AstraZeneca), a pegylated derivative of the opioid
antagonist naloxone, for oral treatment of opioid-induced
constipation in adults with chronic noncancer
pain. It is the only oral opioid antagonist...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.